peoplePerson
Christof von Kalle
Gene therapy pioneer who developed methods to track vector integration in treated patients.
Christof von Kalle developed integration-site analysis that revealed insertional mutagenesis in early gene therapy trials, and led translational oncology at NCT Heidelberg before moving to Berlin.
Role
Director, Clinical Study Center, Berlin Institute of Health at Charité
Institution
Specialisms
Gene therapyCell therapy safetyTranslational research
Profiles